The epiphany when dots are connected
Previous work has demonstrated that optogenetically stimulating D1 MSNs promotes reward, whereas stimulating D2 MSNs produces aversion
The company said that at the end of 2025 it had "supported more than 150,000 members on GLP-1s, compared with more than 50,000 at the end of 2024." "Omada is neither a gatekeeper of GLP-1s nor are we a vending machine," company President Wei-Li Shao says
To get the best from both treatments, it's essential to make healthy lifestyle changes alongside them
Inflammation is co-incident with obesity and diabetes (37), and it is plausible that the observed reduction in the inflammatory response in VSL#3-treated animals (Table 1 and supplemental Tables S1 and S2) might in part account for the overall beneficial phenotype seen in VSL#3-treated animals
Individual results vary based on medication type, dosage, and overall program participation